Sapelizumab: A Novel Targeting CD23 Antibody for Clinical Potential
Sapelizumab, an particular monoclonal antibody, represents the promising therapeutic strategy targeting CD23, the membrane molecule expressed on https://lowendotoxinsapelizumab424305.wikiexpression.com/user